Dry Powder Inhaler Devices Market Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast Report To 2016 Summary GlobalData's Medical Devices sector report, "Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Dry Powder Inhaler Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dry Powder Inhaler Devices pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. Inquire more about this report: http://www.radiantinsights.com/research/dry-powderinhaler-devices-medical-devices-pipeline-assessment-2016 *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Dry Powder Inhaler Devices under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons to Buy The report enables you to - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of Dry Powder Inhaler Devices under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date. Table Of Content: Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 6 2 Introduction 7 2.1 Dry Powder Inhaler Devices Overview 7 3 Products under Development 8 3.1 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development 8 3.2 Dry Powder Inhaler Devices - Pipeline Products by Territory 9 3.3 Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path 10 3.4 Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date 11 3.5 Dry Powder Inhaler Devices - Ongoing Clinical Trials 12 Get Sample Copy of Report Here: http://www.radiantinsights.com/research/dry-powderinhaler-devices-medical-devices-pipeline-assessment-2016#tabs-4 4 Dry Powder Inhaler Devices - Pipeline Products under Development by Companies 13 4.1 Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development 13 4.2 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development 15 5 Dry Powder Inhaler Devices Companies and Product Overview 16 5.1 Acorda Therapeutics, Inc. Company Overview 16 5.1.1 Acorda Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16 5.2 Adamis Pharmaceuticals Corporation Company Overview 19 5.2.1 Adamis Pharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview 19 5.3 Advent Pharmaceuticals Pty Ltd Company Overview 22 5.3.1 Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 22 5.4 Aespira Ltd. Company Overview 23 5.4.1 Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23 5.5 AKELA Pharma Inc. (Inactive) Company Overview 24 5.5.1 AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24 5.6 Bayer HealthCare AG Company Overview 26 5.6.1 Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Bespak Europe Ltd. Company Overview 28 5.7.1 Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28 5.8 GlaxoSmithKline Plc Company Overview 29 5.8.1 GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview 29 5.9 Hovione FarmaCiencia SA Company Overview 31 5.9.1 Hovione FarmaCiencia SA Pipeline Products & Ongoing Clinical Trials Overview 31 5.10 MannKind Corporation Company Overview 33 5.10.1 MannKind Corporation Pipeline Products & Ongoing Clinical Trials Overview 33 5.11 Nanotherapeutics, Inc. Company Overview 35 5.11.1 Nanotherapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35 5.12 Nektar Therapeutics Company Overview 38 5.12.1 Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 38 5.13 Novartis AG Company Overview 40 5.13.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 40 5.14 OPKO Health, Inc. Company Overview 44 5.14.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44 5.15 Pharmaxis Limited Company Overview 46 5.15.1 Pharmaxis Limited Pipeline Products & Ongoing Clinical Trials Overview 46 5.16 Respira Therapeutics, Inc. Company Overview 48 5.16.1 Respira Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48 5.17 Sandoz International GmbH Company Overview 49 5.17.1 Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview 49 5.18 Sheffield Hallam University Company Overview 52 5.18.1 Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview 52 Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/medicaldevices 5.19 Shin Nippon Biomedical Laboratories, Ltd. Company Overview 53 5.19.1 Shin Nippon Biomedical Laboratories, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53 5.20 Teva Pharmaceutical Industries Ltd. Company Overview 55 5.20.1 Teva Pharmaceutical Industries Ltd. Pipeline Products & Ongoing Clinical Trials Overview 55 5.21 University of Kansas Company Overview 57 5.21.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 57 5.22 University of Texas Medical Branch at Galveston Company Overview 58 5.22.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 58 6 Dry Powder Inhaler Devices- Recent Developments 60 6.1 Mar 30, 2016: 80 Years of Innovation and Success in Healthcare: Chiesi Reports Significant International Growth in 2015 60 6.2 Mar 07, 2016: New Health Outcomes Data Reinforce Role of Device Selection and Peak Inspiratory Flow Rate in Treatment of COPD Patients 61
6.3 Oct 20, 2015: GSK announces positive new data comparing Incruse Ellipta to tiotropium and glycopyrronium in patients with COPD 62 6.4 Jun 16, 2015: Consort Medical announces final results 63 7 Appendix 69 7.1 Methodology 69 7.2 About GlobalData 71 7.3 Contact Us 72 7.4 Disclaimer 72 About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com